{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:25:09Z","timestamp":1788830709331,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Genet Genomics"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s00438-026-02472-6","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:26:13Z","timestamp":1781839573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Single-cell transcriptomics identifies key immune-suppressive cells and their driver genes in the bladder cancer microenvironment with prognostic implications"],"prefix":"10.1007","volume":"301","author":[{"given":"Weihang","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangye","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"2472_CR1","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.trecan.2023.01.007","volume":"9","author":"L Arpinati","year":"2023","unstructured":"Arpinati L, Scherz-Shouval R (2023) From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts. Trends Cancer 9:421\u2013443","journal-title":"Trends Cancer"},{"key":"2472_CR2","doi-asserted-by":"crossref","unstructured":"Bhatt D, Kang B, Sawant D, Zheng L, Perez K, Huang Z, Sekirov L, Wolak D, Huang JY, Liu X, DeVoss J, Manzanillo PS, Pierce N, Zhang Z, Symons A, Ouyang W (2021) STARTRAC analyses of scRNAseq data from tumor models reveal T cell dynamics and therapeutic targets. J Exp Med 218(6):e20201329","DOI":"10.1084\/jem.20201329"},{"key":"2472_CR3","doi-asserted-by":"crossref","unstructured":"Bilim V, Kuroki H, Shirono Y, Murata M, Hiruma K, Tomita Y (2022) Advanced bladder cancer: changing the treatment landscape. J Pers Med 12(10):1745","DOI":"10.3390\/jpm12101745"},{"key":"2472_CR4","doi-asserted-by":"publisher","first-page":"1328651","DOI":"10.3389\/fimmu.2023.1328651","volume":"14","author":"F Blanc-Durand","year":"2023","unstructured":"Blanc-Durand F, Clemence Wei Xian L, Tan DSP (2023) Targeting the immune microenvironment for ovarian cancer therapy. Front Immunol 14:1328651","journal-title":"Front Immunol"},{"key":"2472_CR5","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/s41467-025-56462-0","volume":"16","author":"LM Boll","year":"2025","unstructured":"Boll LM, Vazquez Montes de Oca S, Camarena ME, Castelo R, Bellmunt J, Perera-Bel J, Alba MM (2025) Predicting immunotherapy response of advanced bladder cancer through a meta-analysis of six independent cohorts. Nat Commun 16:1213","journal-title":"Nat Commun"},{"key":"2472_CR6","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74:229\u2013263","journal-title":"CA Cancer J Clin"},{"key":"2472_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.euo.2023.02.011","volume":"6","author":"B Caramelo","year":"2023","unstructured":"Caramelo B, Zagorac S, Corral S, Marques M, Real FX (2023) Cancer-associated fibroblasts in bladder cancer: origin, biology, and therapeutic opportunities. Eur Urol Oncol 6:366\u2013375","journal-title":"Eur Urol Oncol"},{"key":"2472_CR8","doi-asserted-by":"publisher","first-page":"986359","DOI":"10.3389\/fimmu.2022.986359","volume":"13","author":"H Chen","year":"2022","unstructured":"Chen H, Yang W, Xue X, Li Y, Jin Z, Ji Z (2022) Neoadjuvant immunotherapy and chemoimmunotherapy for stage II-III muscle invasive bladder cancer. Front Immunol 13:986359","journal-title":"Front Immunol"},{"key":"2472_CR9","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA (2023) The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41:374\u2013403","journal-title":"Cancer Cell"},{"key":"2472_CR10","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1097\/CAD.0000000000001352","volume":"33","author":"X Dian","year":"2022","unstructured":"Dian X, Kun L, Xin W, SongBai Y, Qi L, Liangkuan B (2022) Successful treatment of advanced muscle-invasive bladder cancer with the combined therapy of toripalimab and chemotherapy: a case report. Anticancer Drugs 33:1156\u20131162","journal-title":"Anticancer Drugs"},{"key":"2472_CR11","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/s41586-024-08257-4","volume":"637","author":"A Elewaut","year":"2025","unstructured":"Elewaut A, Estivill G, Bayerl F, Castillon L, Novatchkova M, Pottendorfer E, Hoffmann-Haas L, Schonlein M, Nguyen TV, Lauss M, Andreatta F, Vulin M, Krecioch I, Bayerl J, Pedde AM, Fabre N, Holstein F, Cronin SM, Rieser S, Laniti DD, Barras D, Coukos G, Quek C, Bai X, Munoz IOM, Wiesner T, Zuber J, Jonsson G, Bottcher JP, Vanharanta S, Obenauf AC (2025) Cancer cells impair monocyte-mediated T cell stimulation to evade immunity. Nature 637:716\u2013725","journal-title":"Nature"},{"key":"2472_CR12","doi-asserted-by":"publisher","first-page":"116498","DOI":"10.1016\/j.bcp.2024.116498","volume":"229","author":"P Garg","year":"2024","unstructured":"Garg P, Ramisetty SK, Raghu Subbalakshmi A, Krishna BM, Pareek S, Mohanty A, Kulkarni P, Horne D, Salgia R, Singhal SS (2024) Gynecological cancer tumor microenvironment: unveiling cellular complexity and therapeutic potential. Biochem Pharmacol 229:116498","journal-title":"Biochem Pharmacol"},{"key":"2472_CR13","doi-asserted-by":"publisher","first-page":"655152","DOI":"10.3389\/fcell.2021.655152","volume":"9","author":"X Geng","year":"2021","unstructured":"Geng X, Chen H, Zhao L, Hu J, Yang W, Li G, Cheng C, Zhao Z, Zhang T, Li L, Sun B (2021) Cancer-associated fibroblast (CAF) heterogeneity and targeting therapy of CAFs in pancreatic cancer. Front Cell Dev Biol 9:655152","journal-title":"Front Cell Dev Biol"},{"key":"2472_CR14","unstructured":"GEO database In: https:\/\/portal.gdc.cancer.gov\/"},{"key":"2472_CR15","doi-asserted-by":"publisher","first-page":"3844","DOI":"10.1093\/bioinformatics\/btac409","volume":"38","author":"EK Gustavsson","year":"2022","unstructured":"Gustavsson EK, Zhang D, Reynolds RH, Garcia-Ruiz S, Ryten M (2022) ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2. Bioinformatics 38:3844\u20133846","journal-title":"Bioinformatics"},{"key":"2472_CR16","doi-asserted-by":"publisher","first-page":"e2312855121","DOI":"10.1073\/pnas.2312855121","volume":"121","author":"W Jing","year":"2024","unstructured":"Jing W, Wang G, Cui Z, Li X, Zeng S, Jiang X, Li W, Han B, Xing N, Zhao Y, Chen S, Shi B (2024) Tumor-neutrophil cross talk orchestrates the tumor microenvironment to determine the bladder cancer progression. Proc Natl Acad Sci USA 121:e2312855121","journal-title":"Proc Natl Acad Sci USA"},{"key":"2472_CR17","doi-asserted-by":"crossref","unstructured":"Kurche JS, Stancil IT, Michalski JE, Yang IV, Schwartz DA (2022) Dysregulated cell-cell communication characterizes pulmonary fibrosis. Cells 11(20):3319","DOI":"10.3390\/cells11203319"},{"key":"2472_CR18","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.semcancer.2022.09.004","volume":"86","author":"JH Lee","year":"2022","unstructured":"Lee JH, Massague J (2022) TGF-beta in developmental and fibrogenic EMTs. Semin Cancer Biol 86:136\u2013145","journal-title":"Semin Cancer Biol"},{"key":"2472_CR20","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","volume":"6","author":"K Li","year":"2021","unstructured":"Li K, Shi H, Zhang B, Ou X, Ma Q, Chen Y, Shu P, Li D, Wang Y (2021) Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer. Signal Transduct Target Ther 6:362","journal-title":"Signal Transduct Target Ther"},{"key":"2472_CR21","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s12890-023-02684-1","volume":"23","author":"M Li","year":"2023","unstructured":"Li M, Wei X, Zhang SS, Li S, Chen SH, Shi SJ, Zhou SH, Sun DQ, Zhao QY, Xu Y (2023) Recognition of refractory Mycoplasma pneumoniae pneumonia among Myocoplasma pneumoniae pneumonia in hospitalized children: development and validation of a predictive nomogram model. BMC Pulm Med 23:383","journal-title":"BMC Pulm Med"},{"key":"2472_CR19","doi-asserted-by":"publisher","first-page":"1544348","DOI":"10.3389\/fimmu.2025.1544348","volume":"16","author":"F Li","year":"2025","unstructured":"Li F, Jin C, Pan Y, Zhang Z, Wang L, Deng J, Zhou Y, Guo B, Zhang S (2025) Construction of a stromal cell-related prognostic signature based on a 101-combination machine learning framework for predicting prognosis and immunotherapy response in triple-negative breast cancer. Front Immunol 16:1544348","journal-title":"Front Immunol"},{"key":"2472_CR22","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L (2024) Advances in diagnosis and treatment of bladder cancer. BMJ 384:e076743","journal-title":"BMJ"},{"key":"2472_CR24","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1016\/j.ccell.2022.11.005","volume":"40","author":"Z Ma","year":"2022","unstructured":"Ma Z, Li X, Mao Y, Wei C, Huang Z, Li G, Yin J, Liang X, Liu Z (2022) Interferon-dependent SLC14A1 (+) cancer-associated fibroblasts promote cancer stemness via WNT5A in bladder cancer. Cancer Cell 40:1550\u20131565 e1557","journal-title":"Cancer Cell"},{"key":"2472_CR23","doi-asserted-by":"publisher","first-page":"1418131","DOI":"10.3389\/fimmu.2024.1418131","volume":"15","author":"Y Ma","year":"2024","unstructured":"Ma Y, Sun Y, Guo H, Yang R (2024) Tumor-associated macrophages in bladder cancer: roles and targeted therapeutic strategies. Front Immunol 15:1418131","journal-title":"Front Immunol"},{"key":"2472_CR25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1248\/bpb.b21-00966","volume":"45","author":"T MaruYama","year":"2022","unstructured":"MaruYama T, Chen W, Shibata H (2022) TGF-beta and Cancer Immunotherapy. Biol Pharm Bull 45:155\u2013161","journal-title":"Biol Pharm Bull"},{"key":"2472_CR26","doi-asserted-by":"publisher","first-page":"4376","DOI":"10.1111\/cas.15955","volume":"114","author":"Y Mezawa","year":"2023","unstructured":"Mezawa Y, Wang T, Daigo Y, Takano A, Miyagi Y, Yokose T, Yamashita T, Yang L, Maruyama R, Seimiya H, Orimo A (2023) Glutamine deficiency drives transforming growth factor-beta signaling activation that gives rise to myofibroblastic carcinoma-associated fibroblasts. Cancer Sci 114:4376\u20134387","journal-title":"Cancer Sci"},{"key":"2472_CR27","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.immuni.2023.06.003","volume":"56","author":"MA Moreno Ayala","year":"2023","unstructured":"Moreno Ayala MA, Campbell TF, Zhang C, Dahan N, Bockman A, Prakash V, Feng L, Sher T, DuPage M (2023) CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8 (+) T cell antitumor immunity. Immunity 56:1613\u20131630 e1615","journal-title":"Immunity"},{"key":"2472_CR28","doi-asserted-by":"crossref","unstructured":"O\u2019Neill A, Zakaria N, Bull C, Egan H, Corry SM, Leonard NA, O\u2019Meara C, Howard L, Walsh A, Reidy E, Che J, Peng L, Cao L, Egan LJ, Ritter T, Sheehan M, Canney A, Culligan K, Hogan AM, Hynes SO, Dunne PD, O\u2019Dwyer M, Treacy O, Ryan AE (2025) Stromal cells modulate innate immune cell phenotype and function in colorectal cancer via the Sialic acid\/Siglec axis. J Immunother Cancer 13(10):e012491","DOI":"10.1136\/jitc-2025-012491"},{"key":"2472_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.yexcr.2014.04.009","volume":"326","author":"J Oyanagi","year":"2014","unstructured":"Oyanagi J, Kojima N, Sato H, Higashi S, Kikuchi K, Sakai K, Matsumoto K, Miyazaki K (2014) Inhibition of transforming growth factor-beta signaling potentiates tumor cell invasion into collagen matrix induced by fibroblast-derived hepatocyte growth factor. Exp Cell Res 326:267\u2013279","journal-title":"Exp Cell Res"},{"key":"2472_CR30","doi-asserted-by":"publisher","first-page":"1031924","DOI":"10.3389\/fimmu.2022.1031924","volume":"13","author":"DKJ Pieren","year":"2022","unstructured":"Pieren DKJ, Boer MC, de Wit J (2022) The adaptive immune system in early life: the shift makes it count. Front Immunol 13:1031924","journal-title":"Front Immunol"},{"key":"2472_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.4111\/icu.20230300","volume":"65","author":"R Qin","year":"2024","unstructured":"Qin R, Ma X, Pu S, Shen C, Hu D, Liu C, Wang K, Wang Y (2024) Identification and validation of a signature based on myofibroblastic cancer-associated fibroblast marker genes for predicting prognosis, immune infiltration, and therapeutic response in bladder cancer. Investig Clin Urol 65:263\u2013278","journal-title":"Investig Clin Urol"},{"key":"2472_CR32","doi-asserted-by":"publisher","first-page":"23530","DOI":"10.1038\/s41598-024-74052-w","volume":"14","author":"L Shen","year":"2024","unstructured":"Shen L, Tao C, Zhu K, Cai L, Yang S, Jin J, Ren Y, Xiao Y, Zhang Y, Lai D, Tou J (2024) Key platelet genes play important roles in predicting the prognosis of sepsis. Sci Rep 14:23530","journal-title":"Sci Rep"},{"key":"2472_CR33","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1080\/15384101.2015.1053666","volume":"14","author":"H Shi","year":"2015","unstructured":"Shi H, Jiang H, Wang L, Cao Y, Liu P, Xu X, Wang Y, Sun L, Niu H (2015) Overexpression of monocarboxylate anion transporter 1 and 4 in T24-induced cancer-associated fibroblasts regulates the progression of bladder cancer cells in a 3D microfluidic device. Cell Cycle 14:3058\u20133065","journal-title":"Cell Cycle"},{"key":"2472_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s10120-024-01572-9","volume":"28","author":"R Su","year":"2025","unstructured":"Su R, Sun X, Luo Y, Gu L, Wang F, Dong A, Yamamoto M, Tsukamoto T, Nomura S, Zhao Z, Dai C, Deng G, Zhuang B, He Y, Zhang C, Yin S (2025) SUSD2 (+) cancer-associated fibroblasts in gastric cancer mediate the effect of immunosuppression and predict overall survival and the effectiveness of neoadjuvant immunotherapy. Gastric Cancer 28:245\u2013263","journal-title":"Gastric Cancer"},{"key":"2472_CR35","doi-asserted-by":"publisher","first-page":"1374269","DOI":"10.3389\/fcell.2024.1374269","volume":"12","author":"L Sui","year":"2024","unstructured":"Sui L, Cong Y, Liu M, Liu X, Xu Y, Jiang WG, Ye L (2024) Upregulated bone morphogenetic protein 8A (BMP8A) in triple negative breast cancer (TNBC) and its involvement in the bone metastasis. Front Cell Dev Biol 12:1374269","journal-title":"Front Cell Dev Biol"},{"key":"2472_CR36","unstructured":"TCGA database In: https:\/\/www.ncbi.nlm.nih.gov\/geo\/"},{"key":"2472_CR37","doi-asserted-by":"crossref","unstructured":"Tong Y, Chen Z, Wu J, Huang Q, He Y, Shang H, Xia D, Peng E, Wang Z, Liang X, Tang K (2025) METTL3 promotes an immunosuppressive microenvironment in bladder cancer via m6A-dependent CXCL5\/CCL5 regulation. J Immunother Cancer 13(4):e011108","DOI":"10.1136\/jitc-2024-011108"},{"key":"2472_CR38","doi-asserted-by":"crossref","unstructured":"Tran MA, Youssef D, Shroff S, Chowhan D, Beaumont KG, Sebra R, Mehrazin R, Wiklund P, Lin JJ, Horowitz A, Farkas AM, Galsky MD, Sfakianos JP, Bhardwaj N (2024) Urine scRNAseq reveals new insights into the bladder tumor immune microenvironment. J Exp Med 221(8):e20240045","DOI":"10.1084\/jem.20240045"},{"key":"2472_CR39","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s41568-023-00549-7","volume":"23","author":"M Tsoumakidou","year":"2023","unstructured":"Tsoumakidou M (2023) The advent of immune stimulating CAFs in cancer. Nat Rev Cancer 23:258\u2013269","journal-title":"Nat Rev Cancer"},{"key":"2472_CR40","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1186\/s12967-024-05313-5","volume":"22","author":"L Wang","year":"2024","unstructured":"Wang L, Li X, Xu C, Wang D, Ma C, Wang Z, Li Y, Li Z (2024) Unveiling novel cell clusters and biomarkers in glioblastoma and its peritumoral microenvironment at the single-cell perspective. J Transl Med 22:551","journal-title":"J Transl Med"},{"key":"2472_CR41","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","volume":"19","author":"S Xu","year":"2024","unstructured":"Xu S, Hu E, Cai Y, Xie Z, Luo X, Zhan L, Tang W, Wang Q, Liu B, Wang R, Xie W, Wu T, Xie L, Yu G (2024) Using clusterProfiler to characterize multiomics data. Nat Protoc 19:3292\u20133320","journal-title":"Nat Protoc"},{"key":"2472_CR42","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13046-020-01611-0","volume":"39","author":"GJ Yoshida","year":"2020","unstructured":"Yoshida GJ (2020) Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways. J Exp Clin Cancer Res 39:112","journal-title":"J Exp Clin Cancer Res"},{"key":"2472_CR43","doi-asserted-by":"publisher","first-page":"235237352513220","DOI":"10.1177\/23523735251322017","volume":"11","author":"K Yoshihara","year":"2025","unstructured":"Yoshihara K, Ito K, Kimura T, Yamamoto Y, Urabe F (2025) Single-cell RNA sequencing and spatial transcriptome analysis in bladder cancer: current status and future perspectives. Bladder Cancer 11:23523735251322017","journal-title":"Bladder Cancer"},{"key":"2472_CR44","doi-asserted-by":"publisher","first-page":"216964","DOI":"10.1016\/j.canlet.2024.216964","volume":"593","author":"Y Yu","year":"2024","unstructured":"Yu Y, Liang Y, Xie F, Zhang Z, Zhang P, Zhao X, Zhang Z, Liang Z, Li D, Wang L, Chen Y, Sun L, Niu H, Wang Y (2024) Tumor-associated macrophage enhances PD-L1-mediated immune escape of bladder cancer through PKM2 dimer-STAT3 complex nuclear translocation. Cancer Lett 593:216964","journal-title":"Cancer Lett"},{"key":"2472_CR45","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.1038\/s41467-023-40727-7","volume":"14","author":"S Zhang","year":"2023","unstructured":"Zhang S, Fang W, Zhou S, Zhu D, Chen R, Gao X, Li Z, Fu Y, Zhang Y, Yang F, Zhao J, Wu H, Wang P, Shen Y, Shen S, Xu G, Wang L, Yan C, Zou X, Chen D, Lv Y (2023) Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis. Nat Commun 14:5123","journal-title":"Nat Commun"},{"key":"2472_CR46","doi-asserted-by":"publisher","first-page":"217995","DOI":"10.1016\/j.canlet.2025.217995","volume":"633","author":"D Zhou","year":"2025","unstructured":"Zhou D, Zhang J, Deng X, Lu X, Liu X, Yu J, Zheng H, Dai J (2025) SUSD2 hypersialylation promotes early lung adenocarcinoma progression by driving ECM remodeling and pro-tumorigenic fibroblast activation. Cancer Lett 633:217995","journal-title":"Cancer Lett"},{"key":"2472_CR47","doi-asserted-by":"publisher","first-page":"e18266","DOI":"10.1111\/jcmm.18266","volume":"28","author":"S Zhu","year":"2024","unstructured":"Zhu S, Cheng Q, Zou M, Li C, Tang Y, Xia L, Jiang Y, Gong Z, Tang Z, Tang Y, Luo H, Peng N, Wang X, Dong X (2024) Combining bulk and scRNA-seq to explore the molecular mechanisms governing the distinct efferocytosis activities of a macrophage subpopulation in PDAC. J Cell Mol Med 28:e18266","journal-title":"J Cell Mol Med"}],"container-title":["Molecular Genetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02472-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00438-026-02472-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00438-026-02472-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T03:26:17Z","timestamp":1781839577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00438-026-02472-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["2472"],"URL":"https:\/\/doi.org\/10.1007\/s00438-026-02472-6","relation":{},"ISSN":["1617-4615","1617-4623"],"issn-type":[{"value":"1617-4615","type":"print"},{"value":"1617-4623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study did not involve any human participants or human-derived tissues. Therefore, ethical approval and informed consent were not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"142"}}